BB Biotech AG (BBZA.DE)
BB Biotech AG operates in the Biotechnology industry of the Healthcare sector, headquartered in Kusnacht, CH. The stock last traded at $57.40, up 0.17% on the session, giving a market capitalisation of $3.17B. Its beta of 0.62 implies it has historically moved less than the broad market.
BB Biotech AG functions as an equity investment vehicle, managed by Bellevue Asset Management AG. Its investment mandate extends to publicly traded companies across the globe, with a particular focus on firms engaged in modern biotechnology for medications and diagnostic tools. The construction of its portfolio is driven by a rigorous fundamental analysis. This Swiss-domiciled entity was established on November 9, 1993.
BB Biotech AG is most often compared with the following Healthcare names: